Factors affecting serum concentration of vancomycin in critically ill oliguric pediatric patients receiving continuous venovenous hemodiafiltration.

Vancomycin is known to be unintentionally eliminated by continuous renal replacement therapy, and the protein bound fraction of vancomycin is also known to be different in adults and children. However, there are only a few studies investigating the relationship between the dose of continuous venoven...

Full description

Saved in:
Bibliographic Details
Main Authors: Bongjin Lee, Soo Jung Kim, June Dong Park, Jiun Park, Ae Hee Jung, Sun Hoi Jung, Yu Hyeon Choi, Hee Gyung Kang, Il Soo Ha, Hae Il Cheong
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0199158&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850076380111306752
author Bongjin Lee
Soo Jung Kim
June Dong Park
Jiun Park
Ae Hee Jung
Sun Hoi Jung
Yu Hyeon Choi
Hee Gyung Kang
Il Soo Ha
Hae Il Cheong
author_facet Bongjin Lee
Soo Jung Kim
June Dong Park
Jiun Park
Ae Hee Jung
Sun Hoi Jung
Yu Hyeon Choi
Hee Gyung Kang
Il Soo Ha
Hae Il Cheong
author_sort Bongjin Lee
collection DOAJ
description Vancomycin is known to be unintentionally eliminated by continuous renal replacement therapy, and the protein bound fraction of vancomycin is also known to be different in adults and children. However, there are only a few studies investigating the relationship between the dose of continuous venovenous hemodiafiltration (CVVHDF) parameters and serum concentration of vancomycin in pediatric patients. The aim of this study was to determine clinical and demographic parameters that significantly affect serum vancomycin concentrations. This retrospective cohort study was conducted at a pediatric intensive care unit in a tertiary university children's hospital. Data from oliguric patients who underwent CVVHDF and vancomycin therapeutic drug monitoring were collected. The correlation between factors affecting serum concentration of vancomycin was analyzed using mixed effect model. A total of 177 serum samples undergoing vancomycin therapeutic drug monitoring were analyzed. The median age of study participants was 2.23 (interquartile range, 0.3-11.84) years, and 126 (71.19%) were male patients. Serum concentration of vancomycin decreased significantly as the effluent flow rate (EFR; P < 0.001), dialysate flow rate (DFR; P = 0.009), replacement fluid flow rate (RFFR; P = 0.008), the proportion of RFFR in the sum of DFR and RFFR (P = 0.025), and residual urine output increased. The adjusted R2 of the multivariate regression model was 0.874 (P < 0.001) and the equation was as follows: Vancomycin trough level (mg/L) = (0.283 × daily dose of vancomycin [mg/kg/d]) + (365.139 / EFR [mL/h/kg])-(15.842 × residual urine output [mL/h/kg]). This study demonstrated that the serum concentration of vancomycin was associated with EFR, DFR, RFFR, the proportion of RFFR, and residual urine output in oliguric pediatric patients receiving CVVHDF.
format Article
id doaj-art-63c2f3aa4aee4b5e9d22b933d2aabdb2
institution DOAJ
issn 1932-6203
language English
publishDate 2018-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-63c2f3aa4aee4b5e9d22b933d2aabdb22025-08-20T02:46:02ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01136e019915810.1371/journal.pone.0199158Factors affecting serum concentration of vancomycin in critically ill oliguric pediatric patients receiving continuous venovenous hemodiafiltration.Bongjin LeeSoo Jung KimJune Dong ParkJiun ParkAe Hee JungSun Hoi JungYu Hyeon ChoiHee Gyung KangIl Soo HaHae Il CheongVancomycin is known to be unintentionally eliminated by continuous renal replacement therapy, and the protein bound fraction of vancomycin is also known to be different in adults and children. However, there are only a few studies investigating the relationship between the dose of continuous venovenous hemodiafiltration (CVVHDF) parameters and serum concentration of vancomycin in pediatric patients. The aim of this study was to determine clinical and demographic parameters that significantly affect serum vancomycin concentrations. This retrospective cohort study was conducted at a pediatric intensive care unit in a tertiary university children's hospital. Data from oliguric patients who underwent CVVHDF and vancomycin therapeutic drug monitoring were collected. The correlation between factors affecting serum concentration of vancomycin was analyzed using mixed effect model. A total of 177 serum samples undergoing vancomycin therapeutic drug monitoring were analyzed. The median age of study participants was 2.23 (interquartile range, 0.3-11.84) years, and 126 (71.19%) were male patients. Serum concentration of vancomycin decreased significantly as the effluent flow rate (EFR; P < 0.001), dialysate flow rate (DFR; P = 0.009), replacement fluid flow rate (RFFR; P = 0.008), the proportion of RFFR in the sum of DFR and RFFR (P = 0.025), and residual urine output increased. The adjusted R2 of the multivariate regression model was 0.874 (P < 0.001) and the equation was as follows: Vancomycin trough level (mg/L) = (0.283 × daily dose of vancomycin [mg/kg/d]) + (365.139 / EFR [mL/h/kg])-(15.842 × residual urine output [mL/h/kg]). This study demonstrated that the serum concentration of vancomycin was associated with EFR, DFR, RFFR, the proportion of RFFR, and residual urine output in oliguric pediatric patients receiving CVVHDF.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0199158&type=printable
spellingShingle Bongjin Lee
Soo Jung Kim
June Dong Park
Jiun Park
Ae Hee Jung
Sun Hoi Jung
Yu Hyeon Choi
Hee Gyung Kang
Il Soo Ha
Hae Il Cheong
Factors affecting serum concentration of vancomycin in critically ill oliguric pediatric patients receiving continuous venovenous hemodiafiltration.
PLoS ONE
title Factors affecting serum concentration of vancomycin in critically ill oliguric pediatric patients receiving continuous venovenous hemodiafiltration.
title_full Factors affecting serum concentration of vancomycin in critically ill oliguric pediatric patients receiving continuous venovenous hemodiafiltration.
title_fullStr Factors affecting serum concentration of vancomycin in critically ill oliguric pediatric patients receiving continuous venovenous hemodiafiltration.
title_full_unstemmed Factors affecting serum concentration of vancomycin in critically ill oliguric pediatric patients receiving continuous venovenous hemodiafiltration.
title_short Factors affecting serum concentration of vancomycin in critically ill oliguric pediatric patients receiving continuous venovenous hemodiafiltration.
title_sort factors affecting serum concentration of vancomycin in critically ill oliguric pediatric patients receiving continuous venovenous hemodiafiltration
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0199158&type=printable
work_keys_str_mv AT bongjinlee factorsaffectingserumconcentrationofvancomycinincriticallyilloliguricpediatricpatientsreceivingcontinuousvenovenoushemodiafiltration
AT soojungkim factorsaffectingserumconcentrationofvancomycinincriticallyilloliguricpediatricpatientsreceivingcontinuousvenovenoushemodiafiltration
AT junedongpark factorsaffectingserumconcentrationofvancomycinincriticallyilloliguricpediatricpatientsreceivingcontinuousvenovenoushemodiafiltration
AT jiunpark factorsaffectingserumconcentrationofvancomycinincriticallyilloliguricpediatricpatientsreceivingcontinuousvenovenoushemodiafiltration
AT aeheejung factorsaffectingserumconcentrationofvancomycinincriticallyilloliguricpediatricpatientsreceivingcontinuousvenovenoushemodiafiltration
AT sunhoijung factorsaffectingserumconcentrationofvancomycinincriticallyilloliguricpediatricpatientsreceivingcontinuousvenovenoushemodiafiltration
AT yuhyeonchoi factorsaffectingserumconcentrationofvancomycinincriticallyilloliguricpediatricpatientsreceivingcontinuousvenovenoushemodiafiltration
AT heegyungkang factorsaffectingserumconcentrationofvancomycinincriticallyilloliguricpediatricpatientsreceivingcontinuousvenovenoushemodiafiltration
AT ilsooha factorsaffectingserumconcentrationofvancomycinincriticallyilloliguricpediatricpatientsreceivingcontinuousvenovenoushemodiafiltration
AT haeilcheong factorsaffectingserumconcentrationofvancomycinincriticallyilloliguricpediatricpatientsreceivingcontinuousvenovenoushemodiafiltration